- The COVID pandemic hit, and Arthritis Research Canada scientists reacted quickly to the need for reliable information. Our research evaluated how arthritis and drugs that suppress the immune system influenced the risk of infection and the outcomes of COVID-19. Our research informed public health policy by determining how this high-risk group should be treated and prioritized for vaccination. Our scientists also collaborated across Canada to evaluate the effectiveness of the COVID-19 vaccines in stimulating an immune response to SARS-CoV2 and preventing future COVID-19 infections in immunosuppressed people.
- Arthritis Research Canada’s scientists Dr. Paul Fortin and Dr. Ines Colmegna led research on the impact of COVID-19 on people living with arthritis: I have a Compromised Immune System. How Could COVID-19 Affect Me?
- COVID-19 Vaccine Research Update.
- Born out of the COVID-19 pandemic, a new patient outreach, the Arthritis Wellness Conversations, began. These monthly conversations provided education, support, and encouragement for people living with arthritis.
- The baton passes, Dr. Diane Lacaille becomes Arthritis Research Canada’s new Scientific Director
- Arthritis Research Education Series launched. The Education Series provides an in-depth look at arthritis research and topics that matter to patients, presents information in a user-friendly, multi-media format, and is available on demand.
